Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Oct1 and Oca-B Regulate the Myeloid Leukemic Phenotype

Jillian Jafek, BS, Arvind Shakya, PhD, Pei-Yi Tai, BS, Gerald J Spangrude, PhD, Todd W Kelley, MD, Dean Tantin, PhD

Blood (2016) 128 (22): 2692.

https://doi.org/10.1182/blood.V128.22.2692.2692

Published: 2016

Journal Articles

Transition of Chronic Myeloid Leukemia to Chronic Myelomonocytic Leukemia As a Tool to Observe Development of Chronic Myelomonocytic Leukemia

Jamshid S Khorashad, MD PhD, Srinivas K Tantravahi, Dongqing Yan, PhD, Anna M. Eiring, PhD, Hannah M. Redwine, Amber D. Bowler, Kevin C. Gantz, Keith M Gligorich, PhD, Anthony D Pomicter, MS, Todd W Kelley, MD, Thomas O'Hare, PhD, Michael W Deininger, MD PhD

Blood (2015) 126 (23): 5223.

https://doi.org/10.1182/blood.V126.23.5223.5223

Published: 2015

Journal Articles

Targeted Detection of Copy Number Variants Using a Myeloid Malignancy Next Generation Sequencing Mutation Panel Allows Comprehensive Genetic Analysis Using a Single Testing Method

Wei Shen, PhD, Philippe Szankasi, PhD, Maria Sederberg, MS, Jonathan Schumacher, MS, Kimberly Frizzell, PhD, Elaine P Gee, PhD, Jay L Patel, MD, Sarah T. South, PhD, Xinjie Xu, PhD, Todd W Kelley, MD

Blood (2015) 126 (23): 2887.

https://doi.org/10.1182/blood.V126.23.2887.2887

Published: 2015

Journal Articles

Next Generation Sequencing to Delineate the Mutational Landscape of Chronic Myelomonocytic Leukemia (CMML): Novel Disease Genes and Correlations with Survival

Clinton C. Mason, PhD, Jamshid S. Khorashad, MD PhD, Srinivas K. Tantravahi, MD, Todd W. Kelley, MD, Anthony D. Pomicter, M.S., Anthony J. Iovino, Kimberly R. Reynolds, M.S., Anna M. Eiring, PhD, Matthew S. Zabriskie, BS, Zev Kronenberg, Jeffrey W. Tyner, Brian Dalley, PhD, Kim-Hien T. Dao, DO,PhD, Thomas O'Hare, PhD, Mark Yandell, PhD, Brian J. Druker, Jason R. Gotlib, MD, Michael W. Deininger

Blood (2014) 124 (21): 4637.

https://doi.org/10.1182/blood.V124.21.4637.4637

Published: 2014

Journal Articles

A Recurrent T-Cell Receptor γ Rearrangement of the Vγ9-JγP Type Represents the Major Clone of γδ T-Cells in Normal Individuals and Is Highly Suppressed in Lymphoproliferative Disorders

Philippe Szankasi, PhD, Jonathan Schumacher, M.S., Olga Efimova, MD, Todd W. Kelley, MD

Blood (2014) 124 (21): 1119.

https://doi.org/10.1182/blood.V124.21.1119.1119

Published: 2014

Journal Articles

An Inexpensive Ion Torrent-Based Deep Sequencing Assay Demonstrates Marked Superiority Over Sanger Sequencing For Routine Detection Of BCR-ABL1 Kinase Domain Mutations

Philippe Szankasi, PhD, Jonathan Schumacher, M.S., Todd W. Kelley, MD

Blood (2013) 122 (21): 2722.

https://doi.org/10.1182/blood.V122.21.2722.2722

Published: 2013

Journal Articles

The Number Of Peripheral Blood CD4+CD25+FOXP3+ Regulatory T-Cells Is a Marker Of Response In Patients With JAK2 V617F Positive Myeloproliferative Neoplasms Treated With Pegylated-Interferon-α

Todd W. Kelley, MD, Sabina Swierczek, PhD, Olga Efimova, MD, Andrew R. Wilson, PhD, Soo Jin Kim, MS, Josef Prchal, MD

Blood (2013) 122 (21): 4059.

https://doi.org/10.1182/blood.V122.21.4059.4059

Published: 2013

Journal Articles

Contrasting Requirement for Reactive Oxygen Species for the Suppressive Function of Naturally Occurring Regulatory T Cells but Not Induced Regulatory T Cells.

Todd W. Kelley, MD, Olga Efimova, M.D., Jonathan Schumacher, M.S., Philippe Szankasi, PhD

Blood (2012) 120 (21): 2146.

https://doi.org/10.1182/blood.V120.21.2146.2146

Published: 2012

Journal Articles

Salutary Effect of Pegylated Interferona in PV and ET As Evaluated by Quantitation of Pre- JAK2 V617F and JAK2 V617F -Bearing Stem Cells and Granulocytes and Correlation with Circulating Regulatory T Cells and HSC Cell Cycle Status

Sabina Swierczek, PhD, Todd W. Kelley, MD, Katherine Y King, M.D., Ph.D., Shen Ching-Chieh, Kimberly Hickman, BS, Soo Jin Kim, M.S., Mohamed E Salama, M.D., Margaret A. Goodell, PhD, Josef T. Prchal, MD

Blood (2012) 120 (21): 807.

https://doi.org/10.1182/blood.V120.21.807.807

Published: 2012

Journal Articles

Frequency and Clonality of BCR-ABL Compound Mutations in Chronic Myeloid Leukemia,

Jamshid Khorashad, MD, PhD, Todd W. Kelley, MD, Philippe Szankasi, PhD, Lauren T. Adrian, Christopher A. Eide, Matthew S. Zabriskie, Thoralf Lange, MD, Ira L Kraft, BS, Anna M Eiring, PhD, Thomas O'Hare, Michael W. Deininger

Blood (2011) 118 (21): 3744.

https://doi.org/10.1182/blood.V118.21.3744.3744

Published: 2011

Journal Articles

Detection of FLT3 Internal Tandem Duplications in Acute Myeloid Leukemia by Targeted Multi-Gene Next Generation Sequencing,

David H Spencer, MD/PhD, Haley Abel, Ph.D., Philippe Szankasi, PhD, Todd W. Kelley, MD, Shashikant Kulkarni, PhD, Mark A. Watson, MD, PhD, John D Pfeifer, MD, PhD, Eric J. Duncavage, MD

Blood (2011) 118 (21): 3547.

https://doi.org/10.1182/blood.V118.21.3547.3547

Published: 2011

Journal Articles

Helios Is Not a Reliable Marker to Distinguish Thymus-Derived Natural Regulatory T Cells From Induced Regulatory T Cells: Stimulation Conditions Influence Helios Expression

Todd W. Kelley, MD, Olga Efimova, M.D., Jonathan Schumacher, M.S., Philippe Szankasi, PhD

Blood (2011) 118 (21): 2177.

https://doi.org/10.1182/blood.V118.21.2177.2177

Published: 2011

Journal Articles

Single Center Experience with Screening for JAK2 V617F, cMPL W515L, cMPL W515K, and JAK2 L611V Mutations in MPN. Rarity of JAK2 L611V Does Not Justify Its Routine Screening

Soo Jin Kim, MST, Sabina Swierczek, PhD, Jonathan Schumacher, M.S., Todd W. Kelley, MD, Sherrie L. Perkins, MD, PhD, Josef T. Prchal, MD

Blood (2011) 118 (21): 5167.

https://doi.org/10.1182/blood.V118.21.5167.5167

Published: 2011

Journal Articles

The Antioxidant n-Acetylcysteine Blocks Direct Regulatory T Cell Mediated Suppression of CD4+ Effector T Cells In Vitro

Todd W. Kelley, MD, Olga Efimova, M.D.

Blood (2010) 116 (21): 2765.

https://doi.org/10.1182/blood.V116.21.2765.2765

Published: 2010

Journal Articles

Increased Tumor Infiltrating FOXP3+ Regulatory T-Cells Are Associated with Improved Survival in Classical Hodgkin Lymphoma.

Todd W. Kelley, MD, Brad Pohlman, M.D., Paul Elson, Sc.D., Eric D. Hsi, M.D.

Blood (2006) 108 (11): 2265.

https://doi.org/10.1182/blood.V108.11.2265.2265

Published: 2006

NARROW

Oct1 and Oca-B Regulate the Myeloid Leukemic Phenotype

Transition of Chronic Myeloid Leukemia to Chronic Myelomonocytic Leukemia As a Tool to Observe Development of Chronic Myelomonocytic Leukemia

Targeted Detection of Copy Number Variants Using a Myeloid Malignancy Next Generation Sequencing Mutation Panel Allows Comprehensive Genetic Analysis Using a Single Testing Method

Next Generation Sequencing to Delineate the Mutational Landscape of Chronic Myelomonocytic Leukemia (CMML): Novel Disease Genes and Correlations with Survival

A Recurrent T-Cell Receptor γ Rearrangement of the Vγ9-JγP Type Represents the Major Clone of γδ T-Cells in Normal Individuals and Is Highly Suppressed in Lymphoproliferative Disorders

An Inexpensive Ion Torrent-Based Deep Sequencing Assay Demonstrates Marked Superiority Over Sanger Sequencing For Routine Detection Of BCR-ABL1 Kinase Domain Mutations

The Number Of Peripheral Blood CD4+CD25+FOXP3+ Regulatory T-Cells Is a Marker Of Response In Patients With JAK2 V617F Positive Myeloproliferative Neoplasms Treated With Pegylated-Interferon-α

Contrasting Requirement for Reactive Oxygen Species for the Suppressive Function of Naturally Occurring Regulatory T Cells but Not Induced Regulatory T Cells.

Salutary Effect of Pegylated Interferona in PV and ET As Evaluated by Quantitation of Pre- JAK2 V617F and JAK2 V617F -Bearing Stem Cells and Granulocytes and Correlation with Circulating Regulatory T Cells and HSC Cell Cycle Status

Frequency and Clonality of BCR-ABL Compound Mutations in Chronic Myeloid Leukemia,

Detection of FLT3 Internal Tandem Duplications in Acute Myeloid Leukemia by Targeted Multi-Gene Next Generation Sequencing,

Helios Is Not a Reliable Marker to Distinguish Thymus-Derived Natural Regulatory T Cells From Induced Regulatory T Cells: Stimulation Conditions Influence Helios Expression

Single Center Experience with Screening for JAK2 V617F, cMPL W515L, cMPL W515K, and JAK2 L611V Mutations in MPN. Rarity of JAK2 L611V Does Not Justify Its Routine Screening

The Antioxidant n-Acetylcysteine Blocks Direct Regulatory T Cell Mediated Suppression of CD4+ Effector T Cells In Vitro

Increased Tumor Infiltrating FOXP3+ Regulatory T-Cells Are Associated with Improved Survival in Classical Hodgkin Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only